When you encounter pediatric poisoning cases involving iron, remember that iron toxicity is a medical emergency requiring immediate intervention. Iron poisoning progresses through distinct stages, and early recognition is critical for patient survival.

Answer A is correct because iron toxicity can rapidly progress from initial gastrointestinal symptoms (vomiting, which this child already exhibits) to serious systemic effects including metabolic acidosis, cardiovascular collapse, and multi-organ failure. The child needs immediate transport for potential chelation therapy with deferoxamine, which is the definitive antidote for iron poisoning. Time is crucial - the earlier chelation begins, the better the outcome.

Answer B is wrong because activated charcoal does not effectively bind iron. Unlike many other toxins, iron has poor affinity for activated charcoal, making this intervention ineffective and potentially harmful by delaying proper treatment.

Answer C is incorrect because syrup of ipecac is contraindicated in poisoning cases. It's no longer recommended due to risks of aspiration, electrolyte imbalances, and delay of definitive care. The child has already vomited once, indicating the body's natural response.

Answer D is dangerous because iron poisoning can rapidly deteriorate. The "honeymoon period" between initial symptoms and systemic toxicity can create a false sense of security. Home observation misses the critical window for chelation therapy.

Remember this pattern: For iron poisoning cases on the NREMT, always prioritize immediate transport and preparation for chelation therapy. Iron doesn't respond to typical poisoning interventions like activated charcoal, and the progression can be deceptively rapid.

This patient is exhibiting signs of a severe cholinergic crisis due to organophosphate poisoning. The priority is to manage the life-threatening muscarinic effects (bronchorrhea, bronchospasm, bradycardia) with atropine. Once the patient is atropinized (dried secretions, increased heart rate), pralidoxime (2-PAM) is administered to reactivate acetylcholinesterase and treat the nicotinic effects (muscle weakness, fasciculations). While diazepam may be needed for seizures, managing the ABCs with atropine is the first priority. Epinephrine is not the primary treatment for bradycardia in this context.

The patient's presentation of bradycardia, hypotension, and hyperglycemia is highly suggestive of a calcium channel blocker (CCB) overdose. The primary treatment is intravenous calcium (chloride or gluconate) to overcome the blockade of calcium channels, thereby improving cardiac contractility and conduction. While glucagon can be a useful adjunct, calcium is the first-line antidote. Sodium bicarbonate is for TCA or salicylate overdose. Magnesium sulfate is not indicated.

The clinical triad of autonomic hyperactivity (tachycardia, hypertension, hyperthermia), altered mental status (agitation, confusion), and neuromuscular abnormalities (clonus, hyperreflexia) in a patient taking an SSRI (sertraline) and a potential serotonergic agent (like dextromethorphan in cough medicine) is classic for serotonin syndrome. Prehospital management focuses on supportive care, especially benzodiazepines (e.g., diazepam, lorazepam) to control agitation and muscle activity, which also helps reduce hyperthermia. While cooling is important, benzodiazepines are the primary pharmacologic treatment. Physostigmine is for anticholinergic toxicity, and beta-blockers are not a first-line therapy.

This patient is experiencing a sympathomimetic crisis from methamphetamine, leading to myocardial ischemia. The primary treatment is benzodiazepines (e.g., diazepam), which reduce the central sympathetic outflow, thereby decreasing heart rate, blood pressure, and myocardial oxygen demand. Beta-blockers (like metoprolol) are contraindicated because they can lead to unopposed alpha-adrenergic stimulation, worsening hypertension and coronary vasoconstriction. While nitroglycerin may be used for chest pain, it does not address the underlying sympathomimetic drive and benzodiazepines should be given first. Furosemide is not indicated.

Acetaminophen overdose is often asymptomatic in the early stages (Stage 1, first 24 hours). Activated charcoal is most effective when given within 1-2 hours of ingestion but can be considered up to 4 hours post-ingestion, especially for large overdoses. Given the ingestion was 3 hours ago, it is a reasonable intervention. N-acetylcysteine is the definitive antidote but its administration is guided by serum acetaminophen levels drawn at the hospital and is typically not a prehospital intervention. Syrup of ipecac is no longer recommended. Supportive care alone is insufficient as it misses the window for decontamination.

When you encounter suspected ethylene glycol poisoning, think about the pathophysiology: ethylene glycol is metabolized into toxic compounds including glycolic acid and oxalic acid, which cause severe metabolic acidosis. The key clinical clue here is the child's Kussmaul respirations (deep, rapid breathing), which is the body's compensatory mechanism to blow off CO₂ and correct acidosis.

The correct approach is D - recognizing severe metabolic acidosis and providing rapid transport. Ethylene glycol poisoning creates a life-threatening metabolic acidosis that requires immediate hospital intervention with antidotes like fomepizole or ethanol, along with possible hemodialysis. The Kussmaul respirations indicate the acidosis is already severe enough to trigger respiratory compensation.

A is incorrect because activated charcoal is ineffective against ethylene glycol - it doesn't bind to alcohols or glycols effectively. B misses the mark because while the glucose is on the lower end of normal (70 mg/dL), it's not truly hypoglycemic, and the respiratory distress isn't related to glucose levels. C represents knowledge of hospital treatment but exceeds paramedic scope - IV ethanol administration requires careful dosing and monitoring that's typically done in-hospital under physician supervision.

For NREMT questions about poisonings, focus on recognizing the clinical syndrome and understanding your scope of practice. While you should know about definitive treatments like antidotes, your primary role is often supportive care, symptom recognition, and rapid transport to appropriate facilities where advanced interventions can be performed safely.

When you encounter a patient with suspected digoxin toxicity presenting with severe hyperkalemia and bradycardia, your priority is addressing the life-threatening electrolyte imbalance and cardiac rhythm. This patient shows classic digoxin toxicity signs: visual disturbances (yellow halos), nausea/vomiting, and cardiac conduction abnormalities.

The combination of severe hyperkalemia (6.2 mEq/L) and 3rd-degree AV block creates immediate cardiac risk. Calcium chloride stabilizes cardiac cell membranes, protecting against hyperkalemia-induced arrhythmias, while sodium bicarbonate helps shift potassium intracellularly, lowering serum levels. This dual approach addresses both the membrane instability and begins correcting the electrolyte imbalance.

Answer A (transcutaneous pacing) treats the bradycardia symptomatically but ignores the underlying hyperkalemia, which could trigger fatal arrhythmias during pacing attempts. Answer B (DigiFab) is the definitive treatment for digoxin toxicity but isn't typically available in prehospital settings and doesn't immediately address the hyperkalemia crisis. Answer C (atropine) is ineffective for 3rd-degree AV blocks, as the problem lies below the AV node where atropine has minimal effect, and it doesn't address the dangerous potassium level.

Remember this pattern: when you see hyperkalemia above 6.0 mEq/L with cardiac rhythm disturbances, calcium is your first-line membrane stabilizer, followed by agents that shift potassium intracellularly. Always treat the underlying electrolyte emergency before attempting rhythm interventions that could destabilize an already compromised cardiac system.

When you encounter a patient removed from an environment with a faulty gas furnace, you should immediately suspect carbon monoxide (CO) poisoning. The classic presentation includes headache, nausea, and altered mental status, which this patient demonstrates. The key deceptive finding here is the normal SpO2 reading of 100% on pulse oximetry.

Standard pulse oximeters cannot distinguish between oxyhemoglobin and carboxyhemoglobin (CO bound to hemoglobin). Carboxyhemoglobin appears bright red like oxygenated blood, so the pulse oximeter reads normal or even high oxygen saturation despite the patient being hypoxic at the cellular level. Carbon monoxide has an affinity for hemoglobin that's 200-250 times greater than oxygen, creating a functional anemia where oxygen cannot be delivered to tissues.

Answer D is correct because high-flow oxygen via non-rebreather mask is the definitive treatment for CO poisoning. It competitively displaces carbon monoxide from hemoglobin and reduces the half-life of carboxyhemoglobin from 4-6 hours to approximately 90 minutes.

Answer A addresses a symptom rather than the underlying pathophysiology. Answer B ignores the critical nature of CO poisoning—this patient needs immediate intervention, not just monitoring. Answer C is premature; while the patient is confused, he's maintaining his airway and breathing adequately.

Remember this key point for the NREMT: normal pulse oximetry readings in suspected carbon monoxide poisoning are misleadingly reassuring. Always prioritize high-flow oxygen for any patient with potential CO exposure, regardless of SpO2 readings.

This patient is exhibiting signs of lithium toxicity (neurologic changes, GI distress). A common cause of acute-on-chronic lithium toxicity is the concurrent use of NSAIDs like ibuprofen. NSAIDs can decrease renal clearance of lithium, causing it to accumulate to toxic levels even with normal dosing. Prehospital care involves supportive measures, IV fluids for dehydration, and transport for definitive care, which may include dialysis. It is less likely an intentional overdose given the history, and his symptoms are not consistent with subtherapeutic levels or serotonin syndrome.